Health Canada has authorized Delta 9 Cannabis Inc (OTCMKTS:VRNDF) to sell edible cannabis products, cannabis topical, and cannabis extracts. Chief Executive Officer of Delta, John Arbuthnot, said the approval from Health Canada permitting the sale of cannabis products is a milestone for the company.
Sells cannabis extracts on January 5, 2020
Delta has submitted notifications for innovative nine cannabis products to Health Canada on November 5, 2019. The updated processing license received from Health Canada on December 4, 2019, allows Delta to sell cannabis extracts with effective from January 5, 2020. John said the team at Delta worked relentlessly to introduce dried cannabis extracts, disposable vape oil pens, and vaporizable oil cartridges. According to the CEO, the company will begin shipment of cannabis products in early 2020.
Vaporizable cannabis oils
Delta is currently working with Westleaf Inc., with the help of Westleaf Labs LP for the development of disposable vape pens and vaporizable oil cartridges. These innovative products will comprise cannabis terpenes and distilled cannabis oil. Delta will brand these products under the brand names: Blast, Cruise, and Harmony that comprise active cannabinoids in different concentrations. The customers can buy vape products for recreational use in Q1 2020.
Dried sift cannabis products for recreational use
Delta is developing the sapphire line of sift cannabis (dried) products for recreational use. It sifts the blended products and later refines them. The resulting yellow/ brownish fine powder comprises lower levels of low potency plant materials and higher levels of high potency resin glands. It has a potency of over three times that of dried white flower cannabis. The customers can purchase dried sift cannabis products for recreational use in Q1 next year.
Delivers cannabinoids through nanoparticle technology
In Canada, Delta received an exclusive license to produce, and market products developed using Nanosphere Health Sciences Inc’s patented technology. The cannabinoids are delivered through nanoparticle technology of Nanosphere Health. Both companies are engaged in developing the first product to suit the needs of Canadian customers. Delta will produce intranasal products, transdermal viscous gels, and intraoral products using the nanosphere delivery system. It ensures precise dosage, faster results, and high bioavailability.
Delta focused on expanding the Winnipeg facilities in Q3 2019. The expansion helps the company to produce high-quality cannabis products.
Ventura Cannabis and Wellness Corp (OTCMKTS:CVHIF) Disposes Of Addiction Services Business: Posts Cannabis Revenues Of $1.7 Million In Q1 2021
Post Views: 136 Ventura Cannabis and Wellness Corp (OTCMKTS:CVHIF) reported revenues of $1.7 million from the cannabis business in Q1...
Cronos Group Inc (NASDAQ:CRON) Commences Sale Of Dried Cannabis Products Under Peace Naturals Brand In Israel: Posts $9.9 Million In Revenues In Q2 2020
Post Views: 136 Cronos Group Inc (NASDAQ:CRON) reported revenues of $9.9 million in Q2 2020. It posted a growth of...
Plus Products Inc (OTCMKTS:PLPRF) Introduces High Cubes Brand In The Californian Market For Recreational Use
Post Views: 62 Plus Products Inc (OTCMKTS:PLPRF) unveiled high THC concentrated Gummies under High Cubes Brand for recreational use in...
Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) Introduces Pure Sunfarm Products In Manitoba As Its Terminates Facility Agreements
Post Views: 165 Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) has announced that its cannabis production joint venture Pure Sunfarms has started...
Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada
Post Views: 256 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...
AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) Unveils its NeuCovix™ Test That Can Accurately Classify COVID-19 Neutralization Tests
Post Views: 121 AXIM® Biotechnologies Inc. (OTCMKTS:AXIM) has completed a study focusing on the performance of its NeuCovix™ rapid test...